The real reason sunshine makes you happy: The benefits of vitamin D may surprise you
Everything from our bones, muscles, nerves and even immune system benefits from vitamin D. Now, we're learning that it can affect mental health, too.
Pharmaceutical
The latest pharmaceutical industry news from MarketWatch.
Elon Musk’s brain-implant company Neuralink says it has FDA approval for first human clinical study
Neuralink has been working for years on a brain-computer interface through brain implants.
Compass shares jump as study shows psychedelic-based drug improved depression in cancer patients
Compass shares rose 3% after the London-based mental-health care group reported in a follow-up study that its COMP360 psilocybin treatment, alongside psychological support, led to remission of depression in most cancer pat...
Tilray stock drops nearly 20% after convertible notes offered to help pay down debt
Tilray's share price dropped after hours Thursday after the cannabis company filed a convertible note offering to buy back older ones before Hexo deal closes.
New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare
The Food and Drug Administration is set to announce soon whether it will grant full approval to lecanemab for the treatment of Alzheimer's.
Pfizer wins full FDA approval for oral COVID therapy Paxlovid for adults at high risk of developing severe illness
Pfizer Inc. PFE said Thursday it has received full Food and Drug Administration approval for its Paxlovid oral treatment for COVID-19 for use in adult patients with high risk of developing severe disease. The treatment has...
Most Popular
More Pharmaceutical News
Lockheed Martin is latest U.S. issuer to tap corporate-bond market ahead of potential debt-ceiling turmoil
Lockheed Martin sold $2 billion of bonds this week, split between 5-year, 10-year and 30-year bonds.
FDA approves Innoviva’s bacterial pneumonia treatment
The Food and Drug Administration said Tuesday that it approved Innoviva's Xacduro pneumonia treatment, which fights the Acinetobacter bacteria.
Lowe’s, PacWest, Yelp stocks rally while BJ’s and Zoom Video shares fall, and other stocks on the move
Yelp, Guardant Health and PacWest Bancorp are some of the biggest movers on Tuesday.
Crypto payments to Chinese fentanyl suppliers soared 450% over past year: study
Chinese suppliers of chemicals used in fentanyl production are increasingly relying on cryptocurrency payments to fund their operations.
These stock pickers led the health-fund category over the past 5 years. Here’s where they’re investing now.
Baron Health Care fund managers find growth potential in Medicare Advantage plans, obesity treatments and advances in cancer screening.
Lifecore Biomedical stock climbs 19% on $150 million refinancing deal
Shares of Lifecore Biomedical on Monday climbed 19% to $6.40 in after-hours trading after the company said it secured a new $150 million financing agreement with its long-term customer Alcon.
Micron, Meta and Nike stocks fall and Nio, DraftKings shares rally, and other stocks on the move
Here are some of the bigger stock movers of the day.
Pfizer shares jump 4% after diabetes drug shows weight-loss results
Pfizer PFE stock was up 4.2% on Monday after a study of its diabetes treatment danuglipron found that a high dose of the drug reduced body weight by more than nine pounds over 16 weeks. The research, circulated by the Jour...
FDA advisers vote in favor of Pfizer’s maternal RSV vaccine
If approved, vaccine would be the first in U.S. to protect babies against leading cause of hospitalization
More Americans injured on the job are testing positive for cannabis
Quest Diagnostics, a major U.S. laboratory, recorded a 25-year high in those who have been injured and then tested positive for cannabis in their system.
Why is Elizabeth Holmes going to prison? A recap of how the Theranos founder got here
Holmes, who was convicted of defrauding Theranos investors, is set to begin her 11-year prison sentence on May 30.
Eli Lilly says mid-stage trial of rheumatoid arthritis met its main efficacy goal
Eli Lilly & Co. LLY said Thursday a mid-stage trial of a treatment for rheumatoid arthritis met its main goal for efficacy with similar rates of adverse events between the treatment group and placebo arms. The data was pub...
Bausch Health stock soars after company says rival application for generic version of its IBS drug can’t be approved until 2029
Bausch Health Cos. Inc. BHC on Wednesday said a U.S. district court stuck with an earlier judgment that prevented an application for a rival generic version of its Xifaxan irritable bowel syndrome drug from getting FDA app...
Medication abortion access hangs in balance as appeals court hears mifepristone case
FDA drug approval process at issue in case challenging widely used abortion pill
Comerica leads S&P 500 gainers in regional-bank rally, Target gains and other stocks on the move
The most active shares Wednesday include Container Stores, and Tesla.
FTC sues to block Amgen’s acquisition of Horizon Therapeutics
Deal could allow Amgen to "entrench the monopoly positions" of two Horizon medications, regulators say.
Pfizer borrows $31 billion in mega bond deal as debt issuance picks up ahead of debt-ceiling deadline
Pharmaceutical giant Pfizer secures $31 billion in financing on Tuesday, as companies pick up the borrowing pace ahead of a June U.S. debt-ceiling deadline.
Abortion pill case heads back to federal appeals court: What’s at stake
Case threatens to "wreak havoc" on drug development and approval, drugmakers say
Corrected Here’s the big thing holding up the stock market, says Bank of America
Investors want to see the economy land softly softly, and that is the main thing that will keep assets resilient, say BofA managers.
Horizon shares sink on report that FTC will sue to block takeover by Amgen
Shares of Horizon Therapeutics Inc. plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected to file a lawsuit to block Amgen Inc.'s $27.8 billion acquisition of Horizon.
